Clinical Trial Record

Return to Clinical Trials

High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma


2019-02-01


2026-12


2026-12


30

Study Overview

High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma

Pancreatic cancer patients at UHN who have had a CT at UHN and have surgery planned will undergo a high resolution ultrasound pre-operatively and intra-operatively. This study is being done to see if using high resolution ultrasound before and during surgery will help the doctors accurately diagnose pancreatic ductal adenocarcinoma and identify if the disease has spread to other areas of the body.

N/A

  • Pancreatic Ductal Adenocarcinoma
  • DEVICE: Ultrasound
  • 18-5982

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2019-01-11  

N/A  

2024-10-07  

2019-01-25  

N/A  

2024-10-10  

2019-01-29  

N/A  

2024-10  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Diagnostic


Allocation:
Na


Interventional Model:
Single Group


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
OTHER: High Resolution Ultasound

Diagnostic high resolution ultrasound pre-operatively and intraoperatively

DEVICE: Ultrasound

  • High resolution ultrasound pre-operatively and intra-operatively
Primary Outcome MeasuresMeasure DescriptionTime Frame
High-resolution U/S will be used to measure vascular invasion and regional lymph node metastases in PDACThe U/S results will be compared to pre-operative CT scan to help determine the diagnostic effectiveness of High Resolution USwithin 2 weeks of surgery
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:
    1. Males and females > 18 y 2. PDAC diagnosed by typical imaging findings or pathology 3. Scheduled for surgical resection 4. Contrast enhanced CT scan performed locally at UHN
    Exclusion Criteria:
    1) Inability or unwillingness to provide informed consent

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • PRINCIPAL_INVESTIGATOR: Korosh Khalili, MD, UHN

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available